Trial Profile
Phase 2 Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Abarelix (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 27 Sep 2006 Status change
- 01 Oct 2005 New trial record.